MX vs NBIX
MagnaChip Semiconductor (MX) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
MagnaChip Semiconductor (MX) is a semiconductors company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported MX revenue for 2024-12-31 was $231.7M. Net income was -$54.3M. Revenue was up 0.7% from 2023-12-31 to 2024-12-31. MX currently screens at market cap $285.3M.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
MX currently screens at market cap $285.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the MX and NBIX stock pages for the full models.
Not investment advice.